Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиImmunic Мультипликаторы 2011-2024 | IMUX
Мультипликаторы по годам Immunic
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.6 | -0.5 | -2.4 | -6.9 | -1.8 | -0.2 | -4.9 | -3.9 | -4.4 | -6.6 | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-2.1 | -3.8 | -3.9 | -2.8 | -4.5 | -1.0 | -1.3 | -1.3 | -2.1 | -3.5 | -74.9 | -17.9 | - |
EV (Enterprise Value) |
32.8 млн | -29 млн | 151 млн | 186 млн | 42.7 млн | -2.34 млн | 211 млн | 104 млн | 153 млн | 225 млн | -33 млн | 23.5 млн | 56.8 млн |
EBITDA per Share |
-2.24 | -3.75 | -3.87 | -2.66 | -4.79 | -35.6 | -51.8 | -50.3 | -80.8 | -123 | - | - | - |
EV/EBITDA |
-1.5 | -3.6 | -0.9 | 0.1 | -3.9 | -2.5 | -2.9 | -4.4 | - | - | - | ||
PEG |
0.02 | 0.02 | 0.11 | 0.18 | 0.02 | 0.01 | 0.14 | 0.11 | 0.11 | -0.52 | - | - | - |
P/B |
1.9 | 0.6 | 1.8 | 1.9 | 1.1 | 0.7 | 5.1 | 2.7 | 2.8 | 3.2 | - | - | - |
P/CF |
-0.8 | -1.0 | -2.7 | -6.6 | -2.3 | -0.2 | -6.3 | -4.4 | -4.4 | -7.5 | - | - | - |
ROE % |
-323.57 | -105.91 | -73.12 | -27.72 | -59.85 | -333.75 | -104.06 | -70.10 | -63.19 | -48.86 | - | - | - |
ROA % |
-172.40 | -94.25 | -66.82 | -26.22 | -52.96 | -276.91 | -86.24 | -63.99 | -58.40 | -44.10 | - | - | - |
ROCE % |
-335.55 | -104.20 | -71.78 | -30.71 | -62.89 | -308.07 | -105.09 | -70.48 | -63.23 | -51.47 | - | - | - |
Current Ratio |
2.1 | 9.1 | 11.6 | 15.9 | 4.6 | 5.7 | 5.7 | 11.2 | 12.8 | 10.2 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Immunic
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.51 | -0.54 | -0.58 | - | -0.69 | -0.72 | -0.74 | -0.81 | -0.76 | -0.82 | -1.63 | -0.53 | -0.7 | -0.9 | -0.79 | -0.75 | -0.82 | -1.52 | -5.09 | -5.68 | -2.12 | -3.15 | -0.34 | -0.35 | -0.3 | -0.29 | -0.39 | -0.37 | -0.32 | -0.3 | -0.31 | -0.34 | -0.51 | -0.63 | -0.62 | -0.59 | -0.59 | -0.91 | -24.49 | -22.28 | -16.31 | -14.33 | -22.11 | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.53 | -0.56 | -0.62 | - | -0.66 | -0.68 | -0.76 | - | -0.72 | -0.88 | -1.53 | - | -0.73 | -0.96 | -0.84 | - | -0.91 | -1.55 | -0.11 | - | -1.89 | -2.92 | -0.34 | - | -0.29 | -0.29 | -0.38 | - | -0.31 | -0.29 | -0.3 | - | -0.5 | -0.61 | -0.61 | - | -0.57 | -0.64 | -20.5 | - | -16.1 | -13.6 | -10.2 | - | - | - | - | - | - | - | - |
ROE % |
-128.89 | -101.35 | -83.85 | -51.72 | -68.38 | -62.14 | -59.86 | -69.91 | -60.27 | -55.14 | -47.50 | -27.72 | -33.87 | -39.81 | -57.81 | -59.85 | -27.98 | -6.93 | 28.66 | 17.84 | 108.52 | 76.60 | 41.44 | 34.47 | -94.99 | -87.47 | -78.87 | -70.10 | -62.00 | -59.52 | -61.67 | -63.19 | -65.52 | -63.70 | -55.77 | -48.86 | -11.63 | 17.11 | 41.29 | 73.27 | 50.34 | 34.71 | 20.96 | - | - | - | - | - | - | - | - |
ROA % |
-101.78 | -85.31 | -72.15 | -45.29 | -60.52 | -41.42 | -54.60 | -63.04 | -54.46 | -49.84 | -43.49 | -26.22 | -31.24 | -36.00 | -51.48 | -52.96 | -77.29 | -78.28 | -75.94 | -84.51 | -72.68 | -79.91 | -80.48 | -86.24 | -80.41 | -75.64 | -69.88 | -63.99 | -56.73 | -54.64 | -56.81 | -58.40 | -60.24 | -58.28 | -50.73 | -44.10 | -53.17 | -56.31 | -60.09 | -70.23 | -48.25 | -33.28 | -20.09 | - | - | - | - | - | - | - | - |
ROCE % |
-131.20 | -101.65 | -82.28 | -49.96 | -62.54 | -56.76 | -56.41 | -51.75 | -60.25 | -56.16 | -48.06 | -21.81 | -37.40 | -44.49 | -62.31 | -48.99 | -41.98 | -19.38 | 16.48 | -98.85 | -124.07 | -156.31 | -191.73 | -75.59 | -93.08 | -85.35 | -76.60 | -50.29 | -65.25 | -62.73 | -64.72 | -51.23 | -64.36 | -62.53 | -56.16 | -37.23 | -16.71 | 16.94 | 44.69 | 47.37 | 47.37 | 26.85 | 11.03 | - | - | - | - | - | - | - | - |
Current Ratio |
3.6 | 4.6 | 6.2 | 9.1 | 9.9 | - | 12.5 | 11.6 | 13.9 | 8.9 | 8.9 | 18.5 | 18.5 | 18.5 | 18.5 | 8.7 | 8.7 | 8.7 | 8.7 | 7.0 | 7.0 | 7.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD